UK-based Huma, which uses AI and biomarkers to monitor patients at home and for medical research, raises $130M Series C that it can extend with a $70M debt line (Ingrid Lunden/TechCrunch)

UK-based Huma, which uses AI and biomarkers to monitor patients at home and for medical research, raises $130M Series C that it can extend with a $70M debt line (Ingrid Lunden/TechCrunch)

UK-based Huma, which uses AI and biomarkers to monitor patients at home and for medical research, raises $130M Series C that it can extend with a $70M debt line (Ingrid Lunden/TechCrunch)

UK-based Huma, which uses AI and biomarkers to monitor patients at home and for medical research, raises $130M Series C that it can extend with a $70M debt line (Ingrid Lunden/TechCrunch) https://bit.ly/3eEit2y

Ingrid Lunden / TechCrunch:
UK-based Huma, which uses AI and biomarkers to monitor patients at home and for medical research, raises $130M Series C that it can extend with a $70M debt line  —  While much of the world eagerly watches to see if the vaccination rollout helps curb and eventually stamp out Covid-19 …


Related Posts

0 Response to "UK-based Huma, which uses AI and biomarkers to monitor patients at home and for medical research, raises $130M Series C that it can extend with a $70M debt line (Ingrid Lunden/TechCrunch)"

Post a Comment

THANK YOU

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel